Literature DB >> 7686934

Substance P modulates antigen-induced, IFN-gamma production in murine Schistosomiasis mansoni.

A M Blum1, A Metwali, G Cook, R C Mathew, D Elliott, J V Weinstock.   

Abstract

In murine Schistosomiasis mansoni, granuloma eosinophils make SP. We investigated whether SP affects lymphokine secretion in murine schistosomiasis. SP at > or = 10(-10) M, and other tachykinins at much higher concentrations, substantially increased IFN-gamma secretion from spleen or granuloma inflammatory cells primed in vitro by suboptimal stimulatory concentrations of egg Ag or mitogen. Cells receiving maximal antigenic or mitogenic stimulation were affected marginally. Also, tachykinins induced no IFN-gamma from resting cells receiving no Ag or mitogen stimulation. There are three distinct tachykinin receptors, called NK-1, NK-2 and NK-3. SP binds the NK-1 receptor with highest affinity. Specific NK-1 receptor antagonists blocked all tachykinin-induced, IFN-gamma secretion. An NK-2 receptor inhibitor had no effect. Thus, SP and other tachykinins were acting through an NK-1 receptor. Inflammatory cells from 4-day-old granulomas cultured in vitro secrete IFN-gamma. Yet, there was no measurable IFN-gamma when SP receptor antagonists were added to the cultures. Moreover, animals treated in vivo with the NK-1 receptor antagonist CP-96,345 produced smaller granulomas. This suggested that endogenous SP may be necessary for normal induction of granuloma IFN-gamma secretion and a normal granulomatous response. Granuloma macrophages make somatostatin (SOM) that can decrease IFN-gamma secretion. Yet, IFN-gamma secretion was unaffected when both SP and SOM were in the cell cultures. In conclusion, SP modulates Ag-driven IFN-gamma secretion through a NK-1 receptor. Also, SP and SOM may be components of a natural circuit within inflammation that regulates IFN-gamma production.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686934

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Role of neurokinin-1 receptor in the initiation and maintenance of skin chronic inflammatory diseases.

Authors:  Sherrie J Divito; Adrian E Morelli; Adriana T Larregina
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

2.  A substance P antagonist, RP-67,580, ameliorates a mouse meningoencephalitic response to Trypanosoma brucei brucei.

Authors:  P G Kennedy; J Rodgers; F W Jennings; M Murray; S E Leeman; J M Burke
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

Review 3.  Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis.

Authors:  Susmit Suvas
Journal:  J Immunol       Date:  2017-09-01       Impact factor: 5.422

4.  Substance P is responsible for physiological alterations such as increased chloride ion secretion and glucose malabsorption in cryptosporidiosis.

Authors:  Julio Hernandez; Andrew Lackner; Pyone Aye; Kakali Mukherjee; David J Tweardy; Mary-Ann Mastrangelo; Joel Weinstock; Jeffrey Griffiths; Melinda D'Souza; Shantu Dixit; Prema Robinson
Journal:  Infect Immun       Date:  2006-12-11       Impact factor: 3.441

Review 5.  Substance P, obesity, and gut inflammation.

Authors:  Iordanes Karagiannides; Charalabos Pothoulakis
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-02       Impact factor: 3.243

6.  Interleukin-12 (IL-12) and IL-23 induction of substance p synthesis in murine T cells and macrophages is subject to IL-10 and transforming growth factor beta regulation.

Authors:  Arthur Blum; Tommy Setiawan; Long Hang; Korynn Stoyanoff; Joel V Weinstock
Journal:  Infect Immun       Date:  2008-05-27       Impact factor: 3.441

7.  Analog of somatostatin vapreotide exhibits biological effects in vitro via interaction with neurokinin-1 receptor.

Authors:  Sergei Spitsin; Florin Tuluc; John Meshki; Jian Ping Lai; Richard Tustin Iii; Steven D Douglas
Journal:  Neuroimmunomodulation       Date:  2013-07-05       Impact factor: 2.492

8.  Disturbed immunoregulatory properties of the neuropeptide substance P on lymphocyte proliferation in HIV infection.

Authors:  M J Covas; L A Pinto; R M Victorino
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

Review 9.  Immunologists getting nervous: neuropeptides, dendritic cells and T cell activation.

Authors:  B N Lambrecht
Journal:  Respir Res       Date:  2001-04-19

10.  Histoplasma capsulatum encodes a dipeptidyl peptidase active against the mammalian immunoregulatory peptide, substance P.

Authors:  Kendal G Cooper; Robert Zarnowski; Jon P Woods
Journal:  PLoS One       Date:  2009-04-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.